Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes

European Journal of Immunology

Volumn 32, Issue 3, 2002, Pages 662-670

  Hall, Frances C ^a   Rabinowitz, Joshua D ^a   Busch, Robert ^a   Visconti, Kevin C ^a   Belmares, Michael ^a   Patil, Namrata S ^a   Cope, Andrew P ^a   Patel, Salil ^a   McConnell, Harden M ^a   Mellins, Elizabeth D ^a   Sonderstrup, Grete ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Antigen; Antigen presentation; Epitope; MHC; Peptide; T lymphocyte

Indexed keywords

AUTOANTIGEN; EPITOPE; GLYCOPROTEIN GP 39; HLA DM ANTIGEN; HLA DR4 ANTIGEN;

ACIDITY; ARTICLE; CELL SURFACE; CELLULAR IMMUNITY; COMPLEX FORMATION; CONTROLLED STUDY; DEGRADATION KINETICS; ENDOSOME; EPITOPE MAPPING; HALF LIFE TIME; HUMAN; IMMUNOGENICITY; IN VIVO STUDY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN STABILITY; T LYMPHOCYTE; TRANSGENE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CELL MEMBRANE; CELLS, CULTURED; DNA, COMPLEMENTARY; DROSOPHILA MELANOGASTER; ENDOSOMES; GLYCOPROTEINS; HLA-D ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; HYBRIDOMAS; HYDROGEN-ION CONCENTRATION; IMMUNIZATION; IMMUNODOMINANT EPITOPES; KINETICS; MACROMOLECULAR SUBSTANCES; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES;

EID: 0036201441     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5     Document Type: Article

References (35)

1. The molecular basis of susceptibility to rheumatoid arthritis
2. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles
3. The relation between major histocompatibility complex (MHC) restriction and the capacity of la to bind immunogenic
4. Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire
5. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: Peptide binding, immunodominance and effector functions of T cells
6. The role of MHC class II molecules in susceptibility to type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire
7. An autoantigenic T cell epitope forms unstable complexes with class II MHC: A novel route for escape from tolerance induction
8. Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft
9. Kinetics of peptide binding to the class II MHC protein I-Ek
10. Antigen presentation mediated by recycling of surface HLA-DR molecules
11. Extracellular antigen processing and presentation by immature dendritic cells
12. Functional HLA-DM on the surface of B cells and immature dendritic cells
13. Cutting edge: Editing of recycling class II:Peptide complexes by HLA-DM
14. Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex
15. The duration of antigenic stimulation determines the fate of naive and effector T cells
16. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells
17. Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface
18. Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association
19. Capture and processing of exogenous antigens for presentation on MHC molecules
20. Formation of a highly peptide-receptive state of class II MHC
21. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules
22. The down-regulation of HLA-DM gene expression in rheumatoid arthitis is not related to their promoter polymorphism
23. DM determines the cryptic and immunodominant fate of T cell epitopes
24. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
25. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM
26. Enhanced dissociation of HLA-DR-bound peptides in the presence of
27. pH stability of HLA-DR4 complexes with antigenic peptides
28. Influence of hypoxia in inflammatory synovitis
29. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis
30. Characterization and use of the Drosophila metallothionein promoter in cultured Drosophila melanogaster cells
31. Mediation by HLA-DM of dissociation of peptides from HLA-DR
32. Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM
33. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line
34. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes